Zobrazeno 1 - 2
of 2
pro vyhledávání: '"HIV Fusion Inhibitors/adverse effects/therapeutic use"'
Autor:
David A. Cooper, David M. Asmuth, Richard Haubrich, Howard Mayer, Bernard Hirschel, James Goodrich, Natasa Rajicic, Hernan Valdez
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes, Vol. 54, No 4 (2010) pp. 394-397
OBJECTIVES: To determine factors associated with CD4 responses to maraviroc (MVC)-containing regimens in treatment-experienced patients. METHODS: Forty-eight-week data from MOTIVATE 1 and 2 was used to assess MVC once or twice daily versus placebo (P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::516d3b1a6f9138c61e4be90df3ea9bd6
https://doi.org/10.1097/qai.0b013e3181c5c83b
https://doi.org/10.1097/qai.0b013e3181c5c83b
Autor:
Fätkenheuer, G, Nelson, M, Lazzarin, A, Konourina, I, Hoepelman, Ai, Lampiris, H, Hirschel, B, Tebas, P, Raffi, F, Trottier, B, Bellos, N, Saag, M, Cooper, Da, Westby, M, Tawadrous, M, Sullivan, Jf, Ridgway, C, Dunne, Mw, Felstead, S, Vullo, Vincenzo, VAN DER RYST, E, MOTIVATE AND MOTIVATE STUDY TEAMS
Publikováno v:
New England journal of medicine, 359(14), 1442-1455. Massachussetts Medical Society
New England Journal of Medicine, Vol. 359, No 14 (2008) pp. 1442-1455
New England Journal of Medicine, 359(14), 1442-U46. Massachussetts Medical Society
New England Journal of Medicine, Vol. 359, No 14 (2008) pp. 1442-1455
New England Journal of Medicine, 359(14), 1442-U46. Massachussetts Medical Society
BACKGROUND: We conducted subanalyses of the combined results of the Maraviroc versus Optimized Therapy in Viremic Antiretroviral Treatment-Experienced Patients (MOTIVATE) 1 and MOTIVATE 2 studies to better characterize the efficacy and safety of mara
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58cf25843b7ce4c71bcc5873cfcbf2fa
https://pubmed.ncbi.nlm.nih.gov/18832250
https://pubmed.ncbi.nlm.nih.gov/18832250